6
Oct
2026
Lavipharm SA
Exhibitor at CPHI Milan 2026 stand 16F65, Finished Dosage & Formulation
About Us
Categories
-
Country/Region:Greece
-
On CPHI since:2019
-
Certificates:1
-
Employees:250 - 499
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 16F65, Finished Dosage & Formulation
Products Featured at CPHI Milan 2026
-
Product Nitrong, Trinipatch, Nitrosylon, Triniplas, Keritrina
A latest generation nitroglycerin patch for the treatment of coronary artery disease and heart failure. Transdermal Drug Delivery Systems (TDDS) are one of the pharmaceutical technologies, in which Lavipharm is actively and successfully engaged. TDDSs are placed on the skin and allow specific drug subs... -
Product Fentadur, Dolfen, Durfenta, Opiodur, Fentapon, Lafene
A fentanyl transdermal delivery system, developed by Lavipharm's research laboratories in the USA is a small, thin and easy to adhere patch for the management of chronic pain. It is designed to deliver the analgesic substance fentanyl safely and effectively through the skin. This three-day pa...

